Patients at the National Cancer Centre Singapore with nasopharyngeal cancer, which affects the head and neck, showed significantly higher two-year overall survival rates using immuno-therapy compared with trials in similar settings. Xinhua Patients at the National Cancer Centre Singapore with nasopharyngeal cancer, which affects the head and neck, showed significantly higher two-year overall survival rates using immuno-therapy compared with trials in similar settings. Xinhua
Patients at the National Cancer Centre Singapore with nasopharyngeal cancer, which affects the head and neck, showed significantly higher two-year overall survival rates using immuno-therapy compared with trials in similar settings. Xinhua

Pharmaceuticals

Tech

Why immuno-therapy is leaving markets abuzz across the world

Research into the field that uses the body’s own immune system to help fight cancer creating huge interest among the investment community

Topic |   Pharmaceuticals
Eric Ng
Eric Ng

Updated: 10:11pm, 17 Apr, 2018

Why you can trust SCMP
Patients at the National Cancer Centre Singapore with nasopharyngeal cancer, which affects the head and neck, showed significantly higher two-year overall survival rates using immuno-therapy compared with trials in similar settings. Xinhua Patients at the National Cancer Centre Singapore with nasopharyngeal cancer, which affects the head and neck, showed significantly higher two-year overall survival rates using immuno-therapy compared with trials in similar settings. Xinhua
Patients at the National Cancer Centre Singapore with nasopharyngeal cancer, which affects the head and neck, showed significantly higher two-year overall survival rates using immuno-therapy compared with trials in similar settings. Xinhua
READ FULL ARTICLE